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Abstract
Statistics are the primary tools for assessing relationships and evaluating study questions. Unfortunately, these tools are often misused, either inad-
vertently because of ignorance or lack of planning, or conspicuously to achieve a specified result. Data abuses include the incorrect application of 
statistical tests, lack of transparency and disclosure about decisions that are made, incomplete or incorrect multivariate model building, or exclusion 
of outliers. Individually, each of these actions may completely invalidate a study, and often studies are victim to more than one offense. Increasingly 
there are tools and guidance for researchers to look to, including the development of an analysis plan and a series of study specific checklists, in order 
to prevent or mitigate these offenses.
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Utility of biomedical research is a product of ap-
propriate study design, high quality measures, 
proper selection and application of statistical 
methods, and correct interpretations of analytical 
results. Biostatistics are a set of tools that are used 
to evaluate relationships between results in bio-
medical research. They are essential for furthering 
scientific knowledge and understanding. Unfortu-
nately, statistics can be appropriately used, mis-
used and abused, either through concept or appli-
cation. These concerns have been voiced in the lit-
erature since the 1980s, and are still cogent con-
cerns today (1,2). Concerns include poor planning, 
communication, or understanding of the concep-
tual framework that the statistical tool is being 
used to evaluate. Inappropriate study design is of-
ten the first actions in research, and has been dis-
cussed in the literature (3-5). Problems with data 
collection and analyses follow directly from study 
design and are often poorly described in the litera-
ture. Recently, additional guidance has been pro-
posed regarding reporting of study methods and 
results to improve quality and reduce misconduct 
within biomedical research (6-8).
Computers and statistical software packages have 
increased the complexity with which data can be 
analyzed and, consequently, the use of statistics in 
medical research has also increased. Unfortunate-
ly, though the types of errors may have changed, 
the frequency of statistical misuse has not (9,10). 
These errors are primarily due to inadequate 
knowledge and researchers not seeking support 
from statisticians (9). There is no consensus of opti-
mal methods for biomedical research among bio-
statisticians, either currently or in the past. There 
are many differences of opinion in methodological 
approaches, as exemplified by Frequentist and 
Bayesianist statistical methodology, or statistical 
estimation methods proposed by Fischer, Ney-
man, and Wald among others (11-15). The differ-
ences of opinion are so longstanding entrenched 
that most statistical packages simultaneously pre-
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sent multiple estimation results and allow for se-
lection of different methods depending on the 
type of data and relative strength of each method.
While most misuses of statistics are inadvertent 
and arise from a lack of knowledge or planning, 
others may be deliberate decisions in order to 
achieve a desired statistical result. A recent sys-
tematic review and meta-analysis investigating 
fabrication and falsification of research found that 
33.7% of those surveyed admitted to questionable 
research practices, including modifying results to 
improve the outcome, questionable interpretation 
of data, withholding methodological or analytical 
details, dropping observations or data points from 
analyses because of a “gut feeling that they were 
inaccurate” and deceptive or misleading report of 
design, data or results (3). While it is difficult to dis-
cern the differences between the two, the end re-
sult is often the same, erroneous relationships and 
flawed conclusions that are printed and relied 
upon by others in the field. This report will discuss 
common misuses and abuses of biostatistics from 
an epidemiological perspective and provide some 
guidance on methods to reduce the likelihood for 
these wrongdoings.  
Errors in statistical design
Each statistical test requires certain assumptions 
to be met and types of data (categorical, continu-
ous, etc.) in order to produce valid results. If these 
assumptions are not appropriately considered dur-
ing selection of statistical tests, meaningful errors 
and misinterpretation of results are possible. At best 
errors of this nature may be a slight limitation, and 
at worst may completely invalidate results and their 
associated conclusions (16). In worst case scenari-
os, the research study itself may be entirely com-
promised. It is possible that errors in the applica-
tion of biostatistics may occur at any or all stages of 
a study. Furthermore, a single statistical error can be 
adequate to invalidate any study results (17). Any re-
search investigation can be appropriately planned 
and performed, however, if incorrect analytical ap-
proach is applied the repercussions may be as grave 
as if the investigation was fundamentally flawed in 
either design or execution (17).
Errors in the description and 
presentation of data
Discussions of statistical assumptions are com-
monly absent from many research articles (18,19). 
One study reported that nearly 90% of all the pub-
lished articles evaluated lacked any discussion of 
statistical assumptions (19). More concerning is 
that many articles fail to report which statistical 
tests were utilized during data analysis (20). Only 
stating that tests were used “where appropriate” is 
also grossly inadequate, yet commonly done 
(18,21). Statistical tests are precisely designed for 
specific types of data, and with the vast array of 
tests now available, thorough consideration must 
be given to the assumptions, which guide their se-
lection.
The prevalence of statistical misuse can be ex-
plained by the widespread absence of basic statis-
tical knowledge among the medical community 
(22,23). In a cross-sectional study of faculty and 
students from colleges of medicine, Gore reported 
the 53.87% found statistics to be very difficult, 
52.9% could not correctly define the meaning of P 
value, 36.45% ill-defined standard deviation, and 
50.97% failed to correctly calculate sample size.
Appropriate treatment of outliers
Outliers are observations beyond what is expect-
ed, which may be identified by some statistical 
variation (e.g. 3 standard deviations above or be-
low the mean) or simple face validity (e.g. body 
mass index of 65.0) or consensus based upon on 
clinical reasons. Traditionally, outliers were exclud-
ed from analyses because they were thought to be 
unduly influencing the statistical model, particu-
larly in studies with small sample size (24). While 
this may be true in some instances, researchers 
may consciously or unconsciously exclude valid 
data that don’t fit a pre-defined data pattern or 
hypothesis, therefore committing an error. This 
may be a simple error that will have minimal im-
pact on results, or it can be a fatal error, which will 
completely invalidate results. Arguments for iden-
tification and omission of outliers are common, 
however there is little consensus on the appropri-
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ate treatment of an outlier. The most comprehen-
sive approach is to analyze data with the extreme 
observations included and run a second set of 
analyses excluding these data. Disclosure and 
complete presentation of both sets of analyses will 
allow the readers to arrive at their own conclusions 
regarding relationships between exposures and 
outcomes. Unfortunately, due to multiple reasons 
ranging from malfeasance to word count limita-
tions, these analyses are often not performed or 
presented. Caution should be taken when exclud-
ing any data point, and ideally decisions about 
what should be excluded should be made prior to 
data collection during the design of the study. 
Data transformation and testing for 
normality
Data may be skewed in biomedical research, re-
quiring different statistical tests. Assessment for 
the magnitude of skewness through testing of 
normality is not uniformly performed, and rarely 
reported. Normality can be assessed graphically or 
statistically. If data are not normally distributed, ei-
ther non-parametric analytical techniques should 
be employed or data need to be transformed to a 
normal distribution. Mathematically, data transfor-
mation is relatively simple, however interpretation 
of results can be difficult.
Parametric and non-parametric tests
There are numerous types of statistical misuse. 
Misapplication of nonparametric and parametric 
tests, failure to apply corrections, and disregard for 
statistical independence are just a few (25). Over 
the years, some have attempted to quantify the 
amount of statistical errors present in published 
research articles. Four articles have each reported 
that approximately 50% of articles in medical and 
dental research contain one or more statistical er-
rors (26-28). It is likely that these percentages are 
underestimates because many research publica-
tions omit or conceal data, rendering post-exami-
nation impossible (26).
Similarly, many statistical tests have various ver-
sions and applications. Like the tests themselves, 
the selection of each version must be in accord-
ance with the required assumptions (18). For ex-
ample, student’s t-test is used to compare the 
means for two sets of continuous sample data. If 
the data are paired, meaning each observation in 
one sample has a corresponding observation in 
the other, then a paired t-test is used. For inde-
pendent data, there are different forms of the t-
test depending upon the variance of the samples. 
In cases of equal variance, using a two-sample t-
test is appropriate. For unequal variance, a modi-
fied two-sample test is required. When more than 
two samples are compared, ANOVA should be uti-
lized. For both t-tests and ANOVA, multiple com-
parisons may necessitate adjustment through the 
use of corrections. There is little agreement on 
when or how to adjust for multiple comparisons 
(29).
In an examination of the American Journal of Physi-
ology, Williams et al. discovered that greater than 
half of all the articles employed unpaired or paired 
t-tests (19). Of those articles, approximately 17% 
failed to correctly utilize the t-test for multiple 
comparisons by modifying the test with either the 
Bonferroni or some other correction method (19). 
In the same study, the authors also reported that 
articles which used the ANOVA test did not specify 
whether one-way or two-way designs were select-
ed (19). Likewise, Glantz found, while inspecting 
two journals that approximately half of the articles 
that used statistics employed the t-test in situations 
that required a test for multiple comparisons (2). 
In some cases, these errors have led to incorrect 
conclusions (26). More commonly, the conclusions 
have not been supported by the statistical results. 
In one publication, 72% or f articles lacked statisti-
cal validation for their conclusions (25). 
Transparency - disclosure and a-priori vs. 
post-hoc analytical decisions 
Research transparency is an increasingly impor-
tant topic in biomedical research. The decisions 
that are made, as well as when those decisions are 
made can play a strong role in the interpretation 
of study results. An ideal study has one where all 
potential outcomes are explored prior to data col-
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lection, including common elements such as how 
data are collected, a detailed statistical analysis 
plan, the alpha level for statistical significance and 
what tests of association are going to be per-
formed. There are many advantages to be gained 
having a thorough approach to the design and 
analysis of the study and documenting the deci-
sions that were made. However, there are unfore-
seen situations that arise that often require prompt 
and proper decisions. These can be innocuous 
such as failure of a data collection tool, to blatant 
selection bias to achieve a desired outcome. These 
decisions can easily, and often are, not mentioned 
in article manuscripts.  
Hawthorne effects are potentially found in re-
search studies that conduct observational or inter-
ventional study designs with human participants. 
It is the theory that study participants act differ-
ently when they know they are being watched or 
are aware of their participation in a research study. 
This change in behavior can commonly be found 
in audits for companies, it is not uncommon to see 
an increase in productivity when employees are 
made aware of an audit. Operant conditioning can 
also be blamed on Hawthorne effects, leading to 
results that stray from true behavior or statistical 
results in studies. Although it is difficult to elimi-
nate any deceptive results deriving from Haw-
thorne effects, a pre-planned approached can 
help maintain true and strong statistically signifi-
cant results (30).
Some of the misuse is because of the nature of re-
search dissemination. There is a publication bias, 
where statistically significant results are more like-
ly to be published (31). Publication is important for 
many reasons, including obtaining grants or other 
funding and achieving tenure in an academic insti-
tution. This external pressure to find statistically 
significant results from research may bias some 
scientists to select a statistical method that is more 
likely to yield statistically significant results. Addi-
tionally, the inclusion or exclusion of outliers, or 
even fabrication of data, may be justified in some 
scientists mind. There is a proposal for a registry of 
unpublished social science data that has statisti-
cally insignificant results (32).
The decision to analyze an exposure-outcome re-
lationship should ideally be made prior to data 
collection, i.e. a priori. When analytical decisions 
are made a priori, the data collection process is 
more efficient and researchers are much less likely 
to find spurious relationships. A priori analyses are 
needed for hypothesis testing, and are generally 
considered the stronger category of analytical de-
cisions. Post-hoc or after the fact analyses can be 
useful in exploring relationships and generating 
hypotheses. Often post-hoc analyses are not fo-
cused and include multiple analyses to investigate 
potential relationships without full consideration 
for the suspected causal pathway. These can be 
“fishing” for results where all potential relation-
ships are analyzed. The hazard arises when re-
searchers perform post-hoc analyses and report re-
sults without disclosing that they are post-hoc 
findings. Based on the alpha level of 0.05, it is likely 
that by random chance 1 in 20 relationships will be 
statistically significant but not clinically meaning-
ful. Proper disclosure of how many analyses were 
performed post-hoc, the decision process for how 
those analyses were selected for evaluation, and 
both the statistically significant and insignificant 
results is warranted.  
Epidemiological vs . biostatistical model 
building
Multivariate regression is often used to control for 
confounding and assess for effect modification 
(33). Often when assessing the relationship be-
tween an exposure and outcome there are many 
potential confounding variables to control for 
through statistical adjustment in a multivariate 
model (34). The selection of variables to include in 
a multivariate model is often more art than sci-
ence, with little agreement on the selection pro-
cess, which is often compounded by the complex-
ity of the adjusting variables and theoretical rela-
tionships (34). Purely statistical approaches to 
model building, including forward and backward 
stepwise building may result in different “final” 
main effects models, both in relation to variables 
included and relationships identified (35,36). Reli-
ance on a pre-determined set of rules regarding 
http://dx.doi.org/10.11613/BM.2015.001 Biochemia Medica 2015;25(1):5–11 
  9
Thiese MS. et al. Misuse and abuse of statistics
stoppage of the model building process can im-
prove this process, and have been proposed since 
the 1970s (37).
Directed acyclic graphs (DAGs) have been utilized 
to both mitigate bias and control for confounding 
factors (38). DAGs hold strong potential for proper 
model selection, and may be a viable option for 
proper covariate selection and model creation 
(39). Although there is no consensus on which 
method of model building is most appropriate, 
certain consistencies remain regardless of the 
model building method used. Proper planning pri-
or to data collection and well before analyses 
helps to ensure that variables are appropriately 
collected and analyzed.
Variables to consider as potential 
confounders
Clinically meaningful relationships identified from 
past studies.
•	 Biologically plausible factors based on the pur-
ported causal pathway between the exposure 
and outcome.
•	 Other factors that the researcher may suspect 
would confound the exposure-outcome rela-
tionship.
•	 After identifying a comprehensive list of varia-
bles that may be effect modifiers or confound-
ers, additional analytical elements need to be 
considered and decided upon.
Decisions to make prior to data collection
•	 P-value criteria for potential inclusion in multi-
variate model.
•	 Assessment for colinearity of variables and de-
termination of treatment if colinearity is identi-
fied.
•	 P-value for inclusion in final model.
•	 P-value for inclusion in effect modification (if 
assessing for effect modification).
Relatively few peer-reviewed articles contain any 
description of the number of variables collected, 
criteria for potential inclusion in a multivariate 
model, type of multivariate model building meth-
od used, how many potential variables were in-
cluded in the model, and how many different as-
sessments were performed. 
Interpretation of results
Many statistical packages allow for a multitude of 
analyses and results, however proper interpreta-
tion is key to translation from research to practice. 
Understanding the implications of committing ei-
ther a type I or type II error are key. Type I error is 
the false rejection of the null when the null is true. 
Conversely, type II error is the false acceptance of 
the null hypothesis when the null hypothesis is 
false. Setting alpha levels prior to analyses are im-
portant; however, there are many elements that 
can influence the P-value, including random error, 
bias and confounding. A P-value of 0.051 com-
pared to an alpha level of 0.05 does not mean that 
there is no association, moreover it means that this 
study was not able to detect a statistically signifi-
cant result. Many researchers would argue that 
there may in fact be a relationship but the study 
was not able to detect it. Additionally, committing 
a type II error can most often be influenced by bias 
and lack of sufficient statistical power. Complete 
understanding the implications of potentially 
committing either of these errors, as well as meth-
ods to minimize the likelihood of committing 
these errors should be achieved prior to begin-
ning a study.
How to combat misuse and abuse of 
statistics
There is increasing interest in improvement of sta-
tistical methods for epidemiological studies. These 
improvements include consideration and imple-
mentation of more rigorous epidemiological and 
statistical methods, improved transparency and 
disclosure regarding statistical methods, appropri-
ate interpretation of statistical results and exclu-
sion of data must be explained. 
There are two initiatives aimed at biomedical re-
searchers to improve the design, execution and in-
terpretation of biomedical research. One is termed 
“Statistical Analyses and Methods in the Published 
Literature”, or commonly the “SAMPL Guidelines”, 
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and provides detailed guidelines to reporting of 
statistical methods and analyses by analysis type 
(40). While relatively new, the SAMPL Guidelines 
are a valuable resource when designing a study or 
writing study results. Another initiative is “Strength-
ening Analytical Thinking for Observational Studies” 
(STRATOS) which aims to provide guidance in the 
design, execution and interpretation of observa-
tional studies (4). Additional resources, including 
checklists and guidelines have been presented for 
specific study design types (STROBE, STARD, CON-
SORT, etc.).
Textbooks and biostatistical journals, including Bi-
ometrika, Statistical Methods in Medical Research, 
Statistics in Medicine, and Journal of the American 
Statistical Association, can provide up to date re-
sources for application of statistical analytical 
plans, interpretation of results, and improvement 
of statistical methods. Additionally, there are many 
statistical societies that hold annual meetings that 
can provide additional instruction, guidance, and 
insight.
Furthermore, researchers should strive to stay in-
formed regarding the development and applica-
tion of statistical tests. Statistical tools including 
splines, multiple imputation, and ordinal regres-
sion analyses are becoming increasingly accepted 
and applied within biomedical research. As new 
methods are evaluated and accepted in research, 
there will be an increasing potential for abuse and 
misuse of these methods. 
Perhaps most importantly, researchers should in-
vest adequate time in developing the theoretical 
construct, whether that is through a DAG or sim-
ple listing of exposure measures, outcome meas-
ures, and confounders.  
Conclusion
There has been, and will likely continue to be mis-
use and abuse of statistical tools. Through proper 
planning, application, and disclosure, combined 
with guidance and tools, hopefully researchers will 
continue to design, execute and interpret cutting 
edge biomedical research to further our knowl-
edge and improve health outcomes.
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